Abstract: The present invention relates to the technical field of fault location of distributed energy resources connected flexible DC distribution network, and disclosed a fault location method, system and application of bipolar short-circuit of two-level VSC-type photovoltaic-connected flexible DC distribution network, wherein, directions of positive currents of DC feeders during fault are used to locate a fault section; a bipolar short-circuit distance measurement model covering interactions and responses of systems is established according to equivalent circuits of transient periods; and fault location is done by obtaining a distance to fault with electric parameters and information of the fault.

Abstract: The present application relates to a high temperature carbon dioxide corrosion inhibitor comprising the following components by mass percent: amide compound 15˜50%, organic alkynol 10˜25%, mercaptan acid 5˜15%, piperidine 5˜25%, mercaptopyridine 5˜15%, and solvent 25˜60%. The corrosion inhibitor has excellent corrosion inhibition for CO2 corrosion of oil field water system at a high temperature (150˜250° C.).

Abstract: The present invention relates to methods and pharmaceutical compositions for treating obesity or obesity-related disorders in a subject suffering from or predisposed to developing obesity or an obesity-related disorder, or for inhibiting the infectivity of HIV, by administering oleuropein, an analogue or derivative thereof, or the major metabolites of oleuropein including oleuropein aglycone, hydroxytyrosol, and elenolic acid or their analogues, or derivatives thereof, an iridoid glycoside, or a secoiridoid glycoside or analogues or derivatives thereof, or any combination of the foregoing including olive leave extract. The invention also relates to methods for screening/diagnosing a subject having, or predisposed to having obesity or a related disorder by measuring the expression profiles of an adipogenic gene selected from PPAR?2, LPL and ?P2 gene and gene product, or other adipogenic, lipogenic, or lipolytic genes and gene products in an individual.

Abstract: The present invention relates to an oil recovery process with composition-adjustable multi-component thermal fluid, the process comprises: adding oxygen produced by air together with fuel and water into a reactor, in which the oxygen and the fuel combust to produce flue gas and heat, the heat heats water to generate hot water/steam, and then the flue gas and the hot water/steam are mixed to form multi-component thermal fluid, wherein the purity of oxygen added into the reactor is controlled so as to produce the multi-component thermal fluid with various mass ratios of flue gas to hot water/steam; then the obtained multi-component thermal fluid with various mass ratios of flue gas to hot water/steam are injected into various types of oil reservoirs for oil recovery. The oil recovery process of the present invention is applicable for various types of crude oil reservoirs.

Abstract: The present application relates to a high temperature carbon dioxide corrosion inhibitor comprising the following components by mass percent: amide compound 15˜50%, organic alkynol 10˜25%, mercaptan acid 5˜15%, piperidine 5˜25%, mercaptopyridine 5˜15%, and solvent 25˜60%. The corrosion inhibitor has excellent corrosion inhibition for CO2 corrosion of oil field water system at a high temperature (150˜250° C.).

Abstract: The present invention relates to methods and pharmaceutical compositions for treating obesity or obesity-related disorders in a subject suffering from or predisposed to developing obesity or an obesity-related disorder, or for inhibiting the infectivity of HIV, by administering oleuropein, an analogue or derivative thereof, or the major metabolites of oleuropein including oleuropein aglycone, hydroxytyrosol, and elenolic acid or their analogues, or derivatives thereof, an iridoid glycoside, or a secoiridoid glycoside or analogues or derivatives thereof, or any combination of the foregoing including olive leave extract. The invention also relates to methods for screening/diagnosing a subject having, or predisposed to having obesity or a related disorder by measuring the expression profiles of an adipogenic gene selected from PPAR?2, LPL and ?P2 gene and gene product, or other adipogenic, lipogenic, or lipolytic genes and gene products in an individual.

Abstract: The present invention relates to methods and pharmaceutical compositions for treating obesity or obesity-related disorders in a subject suffering from or predisposed to developing obesity or an obesity-related disorder, or for inhibiting the infectivity of HIV, by administering oleuropein, an analogue or derivative thereof, or the major metabolites of oleuropein including oleuropein aglycone, hydroxytyrosol, and elenolic acid or their analogues, or derivatives thereof, an iridoid glycoside, or a secoiridoid glycoside or analogues or derivatives thereof, or any combination of the foregoing including olive leave extract. The invention also relates to methods for screening/diagnosing a subject having, or predisposed to having obesity or a related disorder by measuring the expression profiles of an adipogenic gene selected from PPAR?2, LPL and ?P2 gene and gene product, or other adipogenic, lipogenic, or lipolytic genes and gene products in an individual.

Abstract: The present invention relates to methods and pharmaceutical compositions for treating obesity or obesity-related disorders in a subject suffering from or predisposed to developing obesity or an obesity-related disorder, or for inhibiting the infectivity of HIV, by administering oleuropein, an analogue or derivative thereof, or the major metabolites of oleuropein including oleuropein aglycone, hydroxytyrosol, and elenolic acid or their analogues, or derivatives thereof, an iridoid glycoside, or a secoiridoid glycoside or analogues or derivatives thereof, or any combination of the foregoing including olive leave extract. The invention also relates to methods for screening/diagnosing a subject having, or predisposed to having obesity or a related disorder by measuring the expression profiles of an adipogenic gene selected from PPAR?2, LPL and ?P2 gene and gene product, or other adipogenic, lipogenic, or lipolytic genes and gene products in an individual.

Abstract: The present invention relates to methods and pharmaceutical compositions for treating obesity or obesity-related disorders in a subject suffering from or predisposed to developing obesity or an obesity-related disorder, or for inhibiting the infectivity of HIV, by administering oleuropein, an analogue or derivative thereof, or the major metabolites of oleuropein including oleuropein aglycone, hydroxytyrosol, and elenolic acid or their analogues, or derivatives thereof, an iridoid glycoside, or a secoiridoid glycoside or analogues or derivatives thereof, or any combination of the foregoing including olive leave extract. The invention also relates to methods for screening/diagnosing a subject having, or predisposed to having obesity or a related disorder by measuring the expression profiles of an adipogenic gene selected from PPAR?2, LPL and ?P2 gene and gene product, or other adipogenic, lipogenic, or lipolytic genes and gene products in an individual.